Compare IZM & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IZM | EDVA |
|---|---|---|
| Founded | 2011 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Beverages (Production/Distribution) |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 2.0M |
| IPO Year | 2021 | 2012 |
| Metric | IZM | EDVA |
|---|---|---|
| Price | $0.68 | $0.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 451.8K |
| Earning Date | 11-17-2026 | 11-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,066.00 |
| Revenue This Year | N/A | $24,377.87 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.39 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.21 | $0.13 |
| 52 Week High | $2.73 | $0.33 |
| Indicator | IZM | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 55.27 |
| Support Level | $0.33 | $0.17 |
| Resistance Level | $0.88 | $0.31 |
| Average True Range (ATR) | 0.06 | 0.01 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 3.94 | 95.45 |
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.